openPR Logo
Press release

Virginiamycin Market Industrial Progress 2018 to 2026 With Top Players Hongcong Xinrunde Chemical Co., Ltd, Xiamen ShengLang SaiChuang Biological Technology Co., Ltd., Manus Aktteva Biopharma

05-21-2019 02:17 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Virginiamycin

Virginiamycin

Virginiamycin is an antibiotic produced by Streptomyces virginiae and belongs to the streptogramin group, which has two synergistic factors: M (hybrid polyketide-peptide) and S (peptide). It is used in the fuel ethanol industry to prevent microbial contamination. Virginiamycin is an antibiotic, which was marketed for vancomycin resistant enterococcus in the U.S. in 1999. It is also used in the agriculture sector specifically in livestock to accelerate the growth of animals and prevent and treat infections. Virginiamycin is a mixture of two principle components of virginiamycin M1 and virginiamycin S1. Virginiamycin controls microbial growth within lumen of gastrointestinal tract by disrupting bacterial protein synthesis.

Download The PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2621

Virginiamycin can also be used as a growth stimulator as it optimizes the absorption and metabolism of nutrients. It also improves the state of small intestine epithelium and inhibits the growth of harmful toxins and metabolites by gut organisms. Virginiamycin is used for the treatment of necrotic enteritis in broiler chickens — a common fatal gastrointestinal disease in poultry.

Virginiamycin Market- Dynamics

Pharmaceutical manufacturers are focused launching new products to address limited availability of Virginiamycin and to enhance their market share. This in turn is expected to augment the market growth. For instance, in January 2019, Phibro Animal Health Corp. announced that its virginiamycin medicated feed additive received regulatory approval by Veterinary Drugs Directorate (VDD), Health Canada, for use in beef cattle. According to Phibro Animal Health Corp., V-max (virginiamycin) is approved for the reduction of incidence of liver abscesses in cattle fed in confinement.

In developing countries there is rapid increase of demand for livestock. In developed countries, demand for livestock is stagnating. Increasing demand for livestock due to growing human population is expected to boost growth of the market. Increasing livestock production leads to high demand for animal feed.

Virginiamycin Market- Competitive Analysis

Key players in the market are focused on development, manufacturing, and marketing of multisource and branded pharmaceuticals, thereby augmenting the market growth. For instance, in January 2017, Huvepharma AD received approval for STAFAC (virginiamycin) plus CLINACOX (diclazuril) combination drug type in chickens for prevention of necrotic enteritis and coccidiosis in broiler chickens.

Key players operating in the global virginiamycin market include, Hongcong Xinrunde Chemical Co., Ltd, Xiamen ShengLang SaiChuang Biological Technology Co., Ltd., Manus Aktteva Biopharma, Alfanzyme, Phibro Animal Health Corporation, Merck Animal Health, Zoetis, Elanco, Virbac, Ceva, and Vetoquinol.

Virginiamycin Market- Regional Dynamics

On the basis of region, the global virginiamycin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The rapid increase in livestock animals is the main reason for North America region to hold a dominant position in the global virginiamycin market over the forecast period in terms of revenue share followed by Europe. The virginiamycin market in this region has been growing due to the necessity for the additional supplements in the diet for a companion as well as livestock animals for appropriate nutrition.

Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/2621

The consumption of virginiamycin is high in Europe, which is expected to drive the virginiamycin market growth in the region. For instance, in January 2017, virginiamycin was approved for use in feed. Upon completion of voluntary conversion from over the counter to veterinary feed directive(VFD), all feed uses of the virginiamycin alone or in a combination, will require the VFD. The proprietary drug names of virginiamycin is Stafac and V-max.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Virginiamycin Market Industrial Progress 2018 to 2026 With Top Players Hongcong Xinrunde Chemical Co., Ltd, Xiamen ShengLang SaiChuang Biological Technology Co., Ltd., Manus Aktteva Biopharma here

News-ID: 1747551 • Views:

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 2026 : Key Players are Roche AG, Thermo Fisher Scientific Inc., Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2026
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Research Report 2018-2026
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insignificant CAGR Till 2025 With Top Players Novartis AG, Celgene Corp, Otsuka Pharmaceutical Co., Sandoz, Dr Reddys Laboratories, Pharmascience
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Virginiamycin

Dietary Trends in Livestock Products to Drive Growth of Virginiamycin Market, Sa …
The shift in food consumption and dietary trends in livestock products is predominantly driving the current day world food economy. In the last several decades, the APEJ region has experienced a significant population increase leading to increased consumption of meat which has been growing at an alarming rate of 4% per annum. Sales Outlook of Virginiamycin as per the Market Survey is fairly positive and expected to register higher market
Increasing effect of dietary antibiotics on intestinal to bring profitable oppor …
Virginiamycin is a streptogramin antibiotic developed by Streptomyces virginiae. It has two synergistic factors: M (hybrid polyketide-peptide) and S (synthetic polyketide-peptide) (peptide). It is used to eliminate microbial pollution in the fuel ethanol sector. Virginiamycin is an antibiotic that was first marketed in the U.S. in 1999 for ciprofloxacin enterococcus. It is also used in agriculture, especially in the animal industry, to help animals develop faster and avoid and cure
Virginiamycin Market – Global Upcoming Demand, Growth Analysis and Forecast ti …
Global Virginiamycin Market Overview Potential human health benefits of antibiotics used in food animals; a case study of virginiamycin. The virginiamycin market is flourishing due to the rapid increase in human population resulting in an increased demand for livestock. The growing livestock production has raised the demand for animal feed and virginiamycin in the global market. To get in-depth information view the report @ https://www.factmr.com/report/2946/virginiamycin-market The virginiamycin market has been growing due
Global Virginiamycin Market Analysis by 2020-2025
Global Info Research offers a latest published report on Virginiamycin Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Virginiamycin Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/Global-Virginiamycin_p508594.html Market Overview The Virginiamycin
Virginiamycin Market Projected to Experience Major Revenue Boost during the Peri …
Global Virginiamycin Market Overview Potential human health benefits of antibiotics used in food animals; a case study of virginiamycin. The virginiamycin market is flourishing due to the rapid increase in human population resulting in an increased demand for livestock. The growing livestock production has raised the demand for animal feed and virginiamycin in the global market. The virginiamycin market has been growing due to the necessity for the additional supplements in
Virginiamycin Market Analysis, Segments, Growth and Value Chain 2018-2028
Global Virginiamycin Market Overview Potential human health benefits of antibiotics used in food animals; a case study of virginiamycin. The virginiamycin market is flourishing due to the rapid increase in human population resulting in an increased demand for livestock. The growing livestock production has raised the demand for animal feed and virginiamycin in the global market. The virginiamycin market has been growing due to the necessity for the additional supplements in